CYTK Financial Facts

Total revenues: 59.05M
Research and development: 19.34M
See Full Income Statement

See Full Balance Sheet

Cytokinetics Inc. (CYTK) Earnings

  |   Expand Research on CYTK
Next EPS Date 7/30/26 EPS Growth Rate -45.5%
Average EPS % Beat Rate -9.7% Revenue Growth Rate -75.3%
Average % Move 1-Wk after EPS +1.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/30/26 Q226 N/A-$1.63 N/A N/A$16.51M N/A N/A N/A
5/5/26 Q126 -$1.67-$1.65 -$0.02$19.35M$8.59M N/A Details
2/24/26 Q425 -$1.50-$1.56 +$0.06$17.76M$7.12M N/A Details
11/5/25 Q325 -$2.55-$1.57 -$0.98$1.93M$6.05M N/A Details
8/7/25 Q225 -$1.12-$1.42 +$0.30$66.76M$2.01M N/A Details
5/6/25 Q125 -$1.36-$1.37 +$0.01$1.6M$3.6M N/A Details
2/27/25 Q424 -$1.26-$1.22 -$0.04$16.93M$1.95M N/A Details
2/20/25 Q424 N/A-$1.22 N/A N/A$1.95M = N/A N/A